Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial (Q34580808)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial |
scientific article |
Statements
1 reference
Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial (English)
1 reference
Hans Konrad Müller-Hermelink
1 reference
Andreas Engert
1 reference
Jeremy Franklin
1 reference
Hans Theodor Eich
1 reference
Corinne Brillant
1 reference
Susanne Sehlen
1 reference
Claudio Cartoni
1 reference
Richard Herrmann
1 reference
Markus Sieber
1 reference
Hans Tesch
1 reference
Astrid Franke
1 reference
Peter Koch
1 reference
Maike de Wit
1 reference
Ursula Paulus
1 reference
Markus Loeffler
1 reference
Rolf-Peter Müller
1 reference
Eckhart Dühmke
1 reference
Volker Diehl
1 reference
2 July 2007
1 reference
1 reference
25
1 reference
23
1 reference
3495-3502
1 reference
Identifiers
1 reference
1 reference